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From an evolutionary point of view, the 
gametes are the cells in the body that matter the most as 
they are the ones who transmit their genes to the next 
generation ensuring continuation of the species. Being 
able to generate mature oocytes in vitro is of great 
interest. Oocytes are the key to totipotency and are able to 
reprogram somatic cells in approximately one day. In 
addition, in contrast to a clump of pluripotent stem cells, 
once the developmental program has started, fertilized 
oocytes develop into a clump of cells with positional 
information and the possibility to differentiate into both 
the embryonic and the extraembryonic lineages that form 
a complete developing and viable organism. How to 
instruct pluripotent stem cells to become oocytes in vitro 
is still unclear and even though the first steps to obtain 
mouse oocytes have recently been successfully 
demonstrated, inducing meiosis progression and 
folliculogenesis in vitro are still far from being 
understood and have not yet been accomplished. In 
humans, the specific molecular niche that leads to correct 
oogenesis is less understood. Here, we discuss the current 
status of in vitro differentiation of human pluripotent 
stem cells into gametes, in particular to oocytes. 
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The biology of the gametes 
 
It is known that the human embryo implants 
around 10 days post-conception, develops an amniotic 
cavity and a yolk sac cavity and produces considerable 
amounts of extraembryonic mesoderm without having 
specified primordial germ cells (PGCs). In fact, in 
humans it is still unclear when and where the PGCs are 
specified, but PGCs have been observed by several 
scientists in the 50’s-60’s in human embryos around 24 
days post conception in the posterior wall of the yolk 
sac, close to the allantois, using alkaline phosphatase 
activity as marker (Chuva de Sousa Lopes and Roelen, 
2010). It is extremely difficult to investigate this issue in 
humans as during this period of pregnancy women 
themselves have not realized they are pregnant. 
Therefore, also the extrinsic inductive signals needed 
for PGC specification during human embryogenesis are 
unknown. By contrast, in the mouse, at least one 
extrinsic signaling pathway has been identified and 
extensively studied, the bone morphogenetic protein 
(BMP) signaling pathway. Without BMPs being 
produced by the extraembryonic tissues, both the 
extraembryonic ectoderm and the visceral endoderm, 
and the whole signaling cascade being in place in the 
mouse posterior epiblast, PGCs will not be specified 
(Lawson et al., 1999; Chuva de Sousa Lopes and 
Roelen, 2010). 
Once specified, the PGCs enter a dynamic and 
complex developmental program that involves a strong 
component of epigenetic reprogramming while the cells 
proliferate and migrate towards the future gonadal 
ridges (Roelen and Lopes, 2008; Fig. 1). We can only 
assume that the developmental program during this 
migratory period is similar between mice and humans. 
However, major differences regarding such fundamental 
issues as PGC markers between mice and humans exist, 
reminding us that an extrapolation between mice and 
humans should be considered with great caution. For 
example, human PGCs do not express two of the most 
characteristic mouse PGC markers, SOX2 (Perrett et al., 
2008) and SSEA1 (or FUT4; Chuva de Sousa Lopes, 
2014, Leiden University Medical Center, The 
Netherlands, unpublished results). Moreover, from week 
4 until week 10 post-conception (or week 6 - week 12 of 
gestation) both male and female post-migratory human 
PGCs do not express VASA (or DDX4), and 
interestingly, once the human PGCs start expressing 
VASA they completely downregulate OCT4 (or 
POU5F1) and NANOG expression (Anderson et al., 
2007); whereas in mice, post-migratory PGCs co-
express VASA, OCT4 and NANOG for some time. 
In addition, the population of murine PGCs is 
rather homogeneous regarding their developmental 
behavior that is strongly determined by time. As an 
exception, in female mice meiosis entry has a clear 
spatial component occurring in a rostro-caudal or 
anterior-posterior wave (Menke et al., 2003; Bullejos 
and Koopman, 2004). In humans, the spatial component 
of germ cell development in females is dominant and 
during the second and third trimester of human 
development there is a pronounced developmental wave 
from the inner part of the ovarian cortex (containing 
more mature PGCs) to the outer part of the ovarian 
cortex (which will contain the least mature PGCs and
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the last ones to mature). Between week 17-35 of gestation, 
the heterogeneous population of germ cells in human 
female ovaries consists of at least three distinct 
populations: oocytes encapsulated in primordial follicles 
localized in the inner part of the cortex, VASA-
positive/OCT4-negative PGCs and OCT4-positive/VASA-
negative PGCs, all observed together in the developing 
ovary in relatively concentric circles (Kurilo, 1981; 
Konishi et al., 1986; Anderson et al., 2007). 
In women and female mice, at birth the oocytes 
are arrested at the prophase of the first meiotic division 
and it is only during puberty that folliculogenesis is 
resumed and that follicle growth and maturation occurs 
resulting in cyclic ovulations during the female’s fertile 
period. In males, after birth, spermatogenesis slowly 
resumes and during puberty the spermatogonia start 
proliferating and undergo continuous cycles of 
differentiation to sperm, in both mice and humans. 
 
 
Figure 1. Schematic representation of oocyte development. After fertilization, the totipotent zygote gives rise to a 
pluripotent inner cell mass. Shortly after formation of the epiblast, segregation of primordial germ cells and somatic 
cells takes place. The primordial germ cells migrate to the developing gonads and signals from the somatic ovarian 
cells will stimulate meiosis entry and further specification of the oocyte. The oocyte enters meiotic arrest, remains at 
the germinal vesicle stage and together with the ovarian granulosa cells forms a follicle. Shortly before ovulation, as 
a result of hormones and cumulus-oocyte interactions the oocyte resumes meiosis and is released from the ovary at 
the metaphase II stage. After fertilization by a sperm cell a new zygote is formed. ICM = inner cell mass; PGC = 
primordial germ cell; GV = germinal vesicle; MII = metaphase II. 
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Why is the oocyte so special? 
 
The mature oocyte is an extremely potent cell. 
Why? For one thing, the oocyte is the only cell of which 
the cytoplasm is capable of accepting a male haploid (n) 
nucleus and to orchestrate the formation of a new 
diploid nucleus from the haploid male and female 
pronuclei. After a diploid (2n) nucleus is formed this 
single cell, now called a zygote, can develop into a 
complete fetus plus all extraembryonic structures that 
include the fetal part of the placenta, the supporting 
membranes (amnion, chorion, yolk sac) and the 
umbilical cord/allantois. Even more remarkably, the 
cytoplasm of a mature oocyte is capable of 
reprogramming any diploid nucleus, including that of a 
fully differentiated somatic cell, within 24 h towards an 
epigenetic state from which a complete organism can be 
formed. This has been first demonstrated by the birth of 
the sheep Dolly (Wilmut et al., 1997), but after the birth 
of Dolly various animals have been successfully cloned 
by somatic cell nuclear transfer using many different 
somatic cells types. Indeed nuclei have even been 
successfully reprogrammed using mature enucleated 
oocytes of species different from that of the nucleus-
donor cell (Narbonne et al., 2012). Exactly which 
components of the mature oocyte cytoplasm are 
responsible for its nuclear reprogramming capacity is 
not known.  
Secondly, the (totipotent) fertilized/diploid 
oocyte can not only give rise to all the different cell 
types that are present in the fetus and the adult, but it 
does so orchestrating the positional information needed 
in a way that all the tissues are instructed to be formed 
in their correct places. And this is extraordinary. 
Although pluripotent embryonic stem cells (ESCs) also 
have the capacity to form all the different cell types 
present in the fetus and adult they lack the ability to 
organize axial polarity. When pluripotent stem cells are 
aggregated and triggered to differentiate into so-called 
embryoid bodies, different tissues can be formed, but 
these will be randomly distributed and the result is a 
disorganized mass of differentiated cells.  
 
But behind every great oocyte are great granulosa 
cells 
 
During maturation, the oocyte itself acquires 
this tremendous developmental potential via interactions 
with the somatic cells in the ovary. After PGCs have 
colonized the developing ovaries, they will become 
surrounded by somatic cells, the granulosa cells, to form 
primordial follicles. Those can stay dormant as 
primordial follicles for decades, but as the oocyte starts 
to grow in size the interactions with the surrounding 
somatic cells become more complex and the follicles 
change from primordial to primary, secondary and 
antral follicles (Li and Albertini, 2013). Although 
during follicular development the oocyte secretes 
proteins to form an acellular protective shell, called the 
zona pellucida, that surrounds the oocyte, this does not 
prevent interactions between granulosa cells and the 
oocytes. Rather, cytoplasmic transzonal projections 
from the granulosa cells contact the oocyte membrane 
via gap junctions and through these connections 
communication between the oocyte and surrounding 
cells is ensured. Indeed the number of these projections 
increases as the ovarian follicle develops and without a 
complex dialogue between the oocyte and surrounding 
somatic cells the oocyte cannot acquire developmental 
competence. During follicular growth, the oocyte is 
arrested at the prophase of the first meiotic division and 
it is only after a sudden rise in the concentration of 
luteinizing hormone (LH) that meiosis is resumed. The 
oocyte then progresses to the metaphase of the second 
meiotic division, when a second meiotic arrest occurs. 
The oocyte ovulates in meiotic arrest and it is only after 
fertilization by the sperm cell that meiosis in the oocyte 
is completed and male and female pronuclei are formed.  
Apart from this nuclear maturation, the oocyte 
cytoplasm also needs to mature. This cytoplasmic 
maturation is much more difficult to monitor and 
visualize than the changes that occur at the nuclear level 
and it is poorly understood at the molecular level. 
Clearly, the oocyte needs to build up a reservoir of 
mRNA and proteins important for events related to 
fertilization and early development before the 
embryonic genome is activated. 
When more knowledge is available about the 
molecular mechanisms important for cytoplasmic and 
nuclear maturation, we may better understand why some 
oocytes can be successfully fertilized in vitro while 
others that appear morphologically normal do not form 
viable embryos after fertilization. Also investigating the 
characteristics of mature oocytes would teach us about 
how to correctly reprogram a (somatic) nucleus in 24 h, 
knowledge that could be used to generate patient-
specific stem cells lines needed for future applications 
in regenerative medicine. However, mature oocytes are 
very difficult to obtain in large number to study and 
consequently it is quite difficult to study some of their 
extraordinary properties. Therefore, there is a huge 
interest in learning how to generate large amounts of 
mature oocytes. 
 
Differentiation of stem cells into oocytes: the germ 
cells 
 
We know that mouse ESCs have the potency to 
form mature oocytes, because when mouse ESCs are 
introduced in mouse blastocysts to generate adult 
animals, a technique used world-wide that resulted in 
the Nobel prize in 2007, those ESCs are able to 
differentiate into the germline and to form functional 
mature oocytes (or sperm). So if mouse ESCs have this 
capacity in vivo, we should be able differentiate mature 
oocytes at least from mouse ESCs in vitro. But this has
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proven to be very challenging indeed. There have been 
several studies reporting the generation of “mature” 
oocytes from mouse ESCs in vitro, based on 
morphology and gene expression, but all without 
showing functionality (Duggal et al., 2014; Sun et al., 
2014). Moreover, these research papers have basically 
failed to show normal meiosis progression in those in 
vitro-derived germ cells (Novak et al., 2006; Nicholas et 
al., 2009; Sun et al., 2014). This block in nuclear 
differentiation with arrest at meiotic entry or 
progression, could perhaps be a consequence of the fact 
that the germline undergoes a complex cascade of 
epigenetic programming events, that includes DNA 
demethylation, rearrangement of histone marks, imprint 
erasure and X chromosome reactivation, that has proven 
difficult to mimic in vitro (Roelen and Lopes, 2008; 
Chuva de Sousa Lopes and Roelen, 2010). Moreover, it 
is becoming obvious that the germ cells need a correct 
molecular niche provided by the somatic compartment 
of the ovary to undergo their developing program 
correctly. Hence, specifying primordial germ cells in 
vitro may not be sufficient to ensure progression to the 
oocyte. In agreement, several reports have shown that 
female germ cells cultured in a male somatic 
environment develop as male germline and vice versa 
(McLaren and Southee, 1997; Adams and McLaren, 
2002), suggesting that the germline is particularly 
sensitive to the molecular niche and the somatic 
environment that leads to sex determination. 
For the development of in vitro differentiation 
protocols to differentiate stem cells into gametes, the 
focus is currently changing from the induction of germ 
cells to recreating the correct cellular niche necessary 
for each step of development. The importance of 
somatic cells in the differentiation of functional germ 
cells has been further illustrated by germ-soma co-
culture experiments. The formation of functional 
gametes from in vitro cultured PGCs has not been 
successful. However, when germ cells from embryonic 
day (E)12.5 mouse gonads were associated together 
with gonadal somatic cells and transplanted under the 
kidney capsule of adult mice, testis- and ovary-like 
tissues formed. Most importantly, these structures were 
demonstrated to contain functional sperm cells and 
oocytes respectively that could give rise to healthy 
offspring (Matoba and Ogura, 2011). 
 
Differentiation of stem cells into oocytes: recreating 
the niche 
 
Based on the work of Nicholas and colleagues 
(2009) and Matoba and Ogura (2011) that underscored 
the importance of the ovary somatic niche to 
differentiation towards oocytes, Hayashi and colleagues 
(2012) have combined a first period of differentiation of 
mouse ESCs in vitro, followed by the ex-vivo co-culture 
with fetal female gonadal tissue and finally the transfer 
to the ovary of female mice in vivo (Nicholas et al., 
2009; Matoba and Ogura, 2011; Hayashi et al., 2012). 
In this mixed “in vitro-in vivo” protocol, mouse ESCs 
were differentiated first to epiblast-like cells, followed 
by exposure to BMP4 and BMP8b to induce the 
formation of primordial germ cell-like cells in vitro. To 
overcome the meiotic arrest, these primordial germ cell-
like cells were then aggregated with female fetal 
gonadal cells, in their natural cellular and molecular 
niche and that resulted in meiotic entry. Moreover, the 
procedure introduced the natural cellular somatic 
environment that contributed with the developing 
granulosa and theca cells important to the assembly of 
follicles. Thereafter, to promote folliculogenesis, this 
“gonadal aggregate” was transplanted to the ovary of 
immunocompromised adult females to be subjected to 
the natural hormonal cycle that would lead to follicle 
maturation.  
Interestingly, using this protocol, all the germ-
like cells introduced matured after several weeks to the 
germinal vesicle stage in one single cycle and were 
retrieved from the ovary before natural ovulation. 
Maturation was then induced in vitro, followed by in 
vitro fertilization of the generated oocytes and transfer 
of the resulting embryos to a foster mother. The 
resulting progeny developed to adulthood and was 
fertile, demonstrating that this mixed “in vitro-in vivo” 
protocol, including this first part of differentiation in 
vitro, was successful and opened a new door to explore 
the molecular niche necessary to mimic the whole 
process of gametogenesis. The same research group 
reported a similar approach using a mixed “in vitro-in 
vivo” protocol to generate mature functional sperm from 
mouse ESCs (Hayashi et al., 2011). 
 
The future of artificial gametes 
 
It remains to be demonstrated that ESCs (or 
other source of pluripotent stem cells including induced 
pluripotent stem cells) can be used to derive mature 
functional gametes in vitro, even though several 
attempts have been reported (Duggal et al., 2014; Sun et 
al., 2014). The generation of functional human germ 
cells in vitro has proven to be even more difficult, 
because we know much less about human 
gametogenesis and the genetic tools available to study 
humans are simply fewer than in mice. The use of 
human stem cells to produce chimera is subjected for 
obvious reasons to strong regulations world-wide and 
has been reported by few groups that have inserted 
human ESCs in mice blastocysts and transferred those 
blastocysts into foster mice for up to a week (James et 
al., 2006; Gafni et al., 2013). Moreover, human ESCs 
are more closely related to mouse epiblast stem cells 
(EpiSCs) than to mouse ESCs (Brons et al., 2007; Tesar 
et al., 2007), and EpiSCs are more reluctant to 
differentiate to PGCs in vitro. In this respect, using the 
recently published protocols to bring human ESCs from 
their primed pluripotency state to a more naïve
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pluripotency state (Chan et al., 2013; Gafni et al., 2013) 
offers new exciting possibilities to generate human 
primordial germ cell-like cells. 
Although patient-specific pluripotent stem cells 
are far from being considered as an alternative to treat 
infertility, there is a great societal interest in achieving 
artificial gametes in the dish, as infertility associated 
with the aging of the population is a growing concern. 
The societal or family pressure for couples to conceive 
children can be perceived as a huge stress factor. In 
addition, the use of gamete donation, in the case of 
aging women, gender issues or infertility is not always a 
legal option. Moreover, even in countries where gamete 
donation is possible, there is a strong preference for 
parents to have a genetic link with their children and to 
be able to recognize own traits and transmit their own 
genetic material to future generations. Families that 
have an IVF-conceived child prefer the following IVF-
conceived children to have a genetic link with the 
previous (genetic brothers or sisters).  
In conclusion, being able to generate patient-
specific artificial gametes in a dish and providing this 
would occur in an efficient, safe and ethically 
acceptable way, would accelerate the generation of 
patient-specific stem cell lines needed for regenerative 
medicine, allow us to understand totipotency and would 
revolutionize the field of human reproduction, 
presenting a solution for psychological and ethical 
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